ACADIA PHARMACEUTICALS INC. (ACAD) Free cash flow 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$105.1MFY2025 · since FY2016: -$209.9M → $105.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $105.1M | -33.1% |
| FY2024 | $157.2M | +844.0% |
| FY2023 | $16.7M | +114.6% |
| FY2022 | -$114.0M | +10.1% |
| FY2021 | -$126.8M | +11.8% |
| FY2020 | -$143.8M | +5.6% |
| FY2019 | -$152.3M | +10.2% |
| FY2018 | -$169.6M | +22.4% |
| FY2017 | -$218.6M | -4.1% |
| FY2016 | -$209.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAD financial trends
ACAD RevenueACAD Net incomeACAD Net marginACAD Gross profitACAD Gross marginACAD Operating incomeACAD Operating marginACAD Operating cash flowACAD Capital expendituresACAD Return on equityACAD Stock buybacksACAD Dividends paidACAD Total assetsACAD Total liabilitiesACAD Shareholders’ equityACAD overview →